Finasteride, identified by its CAS number 98319-26-7, is a pivotal pharmaceutical active ingredient widely recognized for its efficacy in managing two distinct male health conditions: male pattern hair loss (androgenetic alopecia) and benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. As a synthetic 4-azasteroid compound, Finasteride belongs to the class of 5-alpha reductase inhibitors, a classification that underscores its specific mode of action within the human body.

The therapeutic power of Finasteride stems from its ability to specifically inhibit Type II 5-alpha reductase, an intracellular enzyme. This enzyme plays a crucial role in converting testosterone, a primary male hormone, into dihydrotestosterone (DHT). DHT is a potent androgen responsible for the growth of the prostate gland and is also a key factor in the miniaturization of hair follicles on the scalp, leading to hair thinning and loss in genetically predisposed men. By significantly reducing DHT levels, Finasteride helps to shrink the enlarged prostate and promote hair regrowth, offering a targeted approach to these conditions.

For men experiencing male pattern hair loss, Finasteride is typically prescribed at a dosage of 1 milligram (mg) once daily. Patients should understand that noticeable improvements in hair count and density usually require consistent daily use for at least three to six months. The full benefits may take even longer to manifest, and it is crucial to continue taking the medication to maintain the results. Should treatment be discontinued, the hair gained will typically be lost within 12 months, highlighting the importance of adherence to the prescribed regimen.

In the context of benign prostatic hyperplasia (BPH), Finasteride is commonly administered at a higher dosage of 5 mg once daily. This treatment helps alleviate bothersome urinary symptoms associated with an enlarged prostate, such as difficulty initiating urination, a weakened stream, frequent nighttime urination, and a sensation of incomplete bladder emptying. Beyond symptom relief, Finasteride also significantly reduces the size of the prostate gland and has been shown to lower the risk of acute urinary retention and the need for BPH-related surgery. Similar to its use for hair loss, the full therapeutic effect for BPH may take up to six months or even longer to become evident.

It is paramount to observe several important precautions when considering Finasteride. This medication is exclusively for men and is contraindicated for use in women and children. Women who are pregnant or may become pregnant must not handle crushed or broken Finasteride tablets, as the active ingredient can be absorbed through the skin and may cause birth defects in male fetuses. If accidental contact occurs, the area should be washed immediately with soap and water. Furthermore, Finasteride can influence Prostate Specific Antigen (PSA) levels, which are routinely used in prostate cancer screening. Patients should inform their healthcare providers that they are taking Finasteride, as this may affect the interpretation of PSA test results. Any confirmed increase in PSA levels while on Finasteride should be thoroughly evaluated by a physician.

Like all medications, Finasteride may cause side effects, though not everyone experiences them. Common side effects often include a decreased interest in sexual intercourse, difficulty achieving or maintaining an erection, and problems with ejaculation, such as reduced semen volume. These sexual side effects often improve over time but can sometimes persist even after stopping the medication. Less common or rare but serious side effects can include allergic reactions (such as rash, itching, hives, and swelling of the lips, tongue, or face), breast pain or tenderness, lumps in the breast area, nipple discharge (which could indicate male breast cancer), and, rarely, mood changes including depression or thoughts of self-harm. Any concerning symptoms, particularly changes in breast tissue or severe mood disturbances, should be reported to a healthcare professional immediately.

As a leading manufacturer and supplier of high-quality pharmaceutical raw materials, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing premium Finasteride (CAS 98319-26-7) to meet the global demand. For those looking to buy or purchase this essential raw material, understanding the product's attributes, quality certifications, and competitive price is crucial. We encourage inquiries from pharmaceutical companies, research institutions, and distributors seeking a reliable partner for their active pharmaceutical ingredient needs. Our commitment to stringent quality control ensures that our Finasteride raw powder meets the highest industry standards for purity and effectiveness.